All Stories

  1. Structural Insight on GPR119 Agonist as Potential Therapy for Type II Diabetes: A Comprehensive Review

    Article • Mini-Reviews in Medicinal Chemistry, November 2023, Bentham Science Publishers

    Mr. Shivam Kumar Kori, vivek asati, shivangi agarwal, Arun Iyer, Priyanshu Nema

  2. A Mini-review on Recent Strategies and Applications of Nanomedicines to Combat Antimicrobial Resistance

    Article • Current Drug Metabolism, June 2023, Bentham Science Publishers

    Mr Balak Das Kurmi, vivek asati

  3. Recent Updates on Structural Aspects of ALK Inhibitors as an Anticancer Agent

    Article • Anti-Cancer Agents in Medicinal Chemistry, May 2023, Bentham Science Publishers

    Dr ADARSH SAHU, vivek asati, Md Shahid Ayaz, Parvati Singh

  4. Recent Updates on Indole Derivatives as Kinase Inhibitors in the Treatment of Cancer

    Article • Anti-Cancer Agents in Medicinal Chemistry, February 2023, Bentham Science Publishers

    vivek asati, Kamalpreet Kaur

  5. Structural Perspective of Benzophenones Targeting Tubulin as Anticancer Agents

    Article • Mini-Reviews in Medicinal Chemistry, January 2023, Bentham Science Publishers

    shivangi agarwal, Prof Ratnesh Das, vivek asati

  6. An insight on medicinal attributes of pyrimidine scaffold: An updated review

    Article • Journal of Heterocyclic Chemistry, November 2022, Wiley

    vivek asati

  7. An Investigative Review for Pharmaceutical Analysis of Fenofibrate

    Article • Journal of Chromatographic Science, September 2022, Oxford University Press (OUP)

    vivek asati

  8. Recent Advances in PI3 Kinase Inhibitors: Anticancer Activities and Structure-Activity Relationships

    Article • Mini-Reviews in Medicinal Chemistry, September 2022, Bentham Science Publishers

    vivek asati

  9. Quality by design assisted high‐performance liquid chromatography parameters for simultaneous estimation of simvastatin and fenofibrate

    Article • Separation Science Plus, August 2022, Wiley

    vivek asati

  10. Structural Aspects of mTOR Inhibitors: Search for Potential Compounds

    Article • Anti-Cancer Agents in Medicinal Chemistry, April 2022, Bentham Science Publishers

    vivek asati, Kamalpreet Kaur

  11. Integrated Computational Analysis on Some Indolo-quinoline Derivatives for the Development of Novel Antiplasmodium Agents: CoMFA, Pharmacophore Mapping, Molecular Docking and ADMET Studies

    Article • Current Signal Transduction Therapy, April 2022, Bentham Science Publishers

    vivek asati, Prof Ratnesh Das, Arun Iyer

  12. Discovery of Novel Antimalarial Drugs Based on Thiosemicarbazone Derivatives: An In Silico Approach

    Article • Current Signal Transduction Therapy, April 2022, Bentham Science Publishers

    vivek asati, Kamalpreet Kaur

  13. An analytical review for the estimation of montelukast sodium

    Article • Separation Science Plus, March 2022, Wiley

    vivek asati

  14. In-silico studies for the development of novel RET inhibitors for cancer treatment

    Article • Journal of Molecular Structure, March 2022, Elsevier

    vivek asati

  15. A Computational approach to discover potential quinazoline derivatives against CDK4/6 kinase

    Article • Journal of Molecular Structure, December 2021, Elsevier

    vivek asati

  16. Pyrazolopyrimidines as anticancer agents: A review on structural and target-based approaches

    Article • European Journal of Medicinal Chemistry, December 2021, Elsevier

    vivek asati

  17. Design, Synthesis and Molecular Modeling Studies of Thiosemicarbazone & Thiazole Derivatives as Potential Anti-Malarial Agents

    Article • July 2021, Research Square

    vivek asati

  18. Discovery of novel ALK2 inhibitors of pyrazolo-pyrimidines: A computational study

    Article • Journal of Biomolecular Structure and Dynamics, July 2021, Taylor & Francis

    vivek asati

  19. Current Insights into the Chemistry and Antitubercular Potential of Benzimidazole and Imidazole Derivatives

    Article • Mini-Reviews in Medicinal Chemistry, March 2021, Bentham Science Publishers

    shivangi agarwal, vivek asati, Prof Ratnesh Das, Akash Rathore

  20. Integrated computational approach on sodium-glucose co-transporter 2 (SGLT2) Inhibitors for the development of novel antidiabetic agents

    Article • Journal of Molecular Structure, March 2021, Elsevier

    vivek asati

  21. The Recent Development of Piperazine and Piperidine Derivatives as Antipsychotic Agents

    Article • Mini-Reviews in Medicinal Chemistry, February 2021, Bentham Science Publishers

    vivek asati, shivangi agarwal, Akash Rathore

  22. Structural prediction of novel pyrazolo-pyrimidine derivatives against PIM-1 kinase: In-silico drug design studies

    Article • Journal of Molecular Structure, October 2020, Elsevier

    vivek asati

  23. An exhaustive perspective on structural insights of SGLT2 inhibitors: A novel class of antidiabetic agent

    Article • European Journal of Medicinal Chemistry, October 2020, Elsevier

    vivek asati

  24. Anti-Inflammatory activity of seeds extract of datura stramonium against carrageenan induced paw edema on albino wistar rats

    Article • Journal of Pharmaceutical and Biological Sciences, July 2019, Innovative Publication

    vivek asati

  25. 3D-QSAR and Molecular Docking Studies on Oxadiazole Substituted Benzimidazole Derivatives: Validation of Experimental Inhibitory Potencies Towards COX-2

    Article • Current Computer - Aided Drug Design, July 2019, Bentham Science Publishers

    vivek asati, Sanjay Kumar Bharti

  26. Perspectives of medicinally privileged chalcone based metal coordination compounds for biomedical applications

    Article • European Journal of Medicinal Chemistry, July 2019, Elsevier

    vivek asati

  27. PIM kinase inhibitors: Structural and pharmacological perspectives

    Article • European Journal of Medicinal Chemistry, June 2019, Elsevier

    vivek asati

  28. An updated patent review of therapeutic applications of chalcone derivatives (2014-present)

    Article • Expert Opinion on Therapeutic Patents, May 2019, Taylor & Francis

    vivek asati, Sanjay Kumar Bharti

  29. Recent Perspectives Of Chalcone-Based Molecules As Protein Tyrosine Phosphatase 1b (Ptp1b) Inhibitors

    Article • February 2019, Taylor & Francis

    vivek asati

  30. Formulation and evaluation of sustain released matrix tablet of atenolol

    Article • Journal of Drug Delivery and Therapeutics, January 2019, Society of Pharmaceutical Tecnocrats

    vivek asati

  31. RECENT THERAPEUTIC PROGRESS OF CHALCONE SCAFFOLD BEARING COMPOUNDS AS PROSPECTIVE ANTI-GOUT CANDIDATES

    Article • Journal of Critical Reviews, January 2019, SynthesisHub Advance Scientific Research

    vivek asati

  32. Design, synthesis and molecular modeling studies of novel thiazolidine-2,4-dione derivatives as potential anti-cancer agents

    Article • Journal of Molecular Structure, February 2018, Elsevier

    vivek asati

  33. Virtual Screening, Molecular Docking, and DFT Studies of Some Thiazolidine-2,4-diones as Potential PIM-1 Kinase Inhibitors

    Article • ChemistrySelect, January 2018, Wiley

    vivek asati

  34. Chalcone Derivatives: Anti-inflammatory Potential and Molecular Targets Perspectives

    Article • Current Topics in Medicinal Chemistry, November 2017, Bentham Science Publishers

    vivek asati, Sanjay Kumar Bharti

  35. MEK inhibitors in oncology: a patent review (2015-Present)

    Article • Expert Opinion on Therapeutic Patents, June 2017, Taylor & Francis

    vivek asati, Sanjay Kumar Bharti

  36. SWFB and GA Strategies for Variable Selection in QSAR Studies for the Validation of Thiazolidine- 2,4-Dione Derivatives as Promising Antitumor Candidates

    Article • Indian Journal of Pharmaceutical Education and Research, June 2017, EManuscript Services

    vivek asati

  37. 3D-QSAR and virtual screening studies of thiazolidine-2,4-dione analogs: Validation of experimental inhibitory potencies towards PIM-1 kinase

    Article • Journal of Molecular Structure, April 2017, Elsevier

    vivek asati

  38. Nature Inspired Green Fabrication Technology for Silver Nanoparticles

    Article • Current Nanomedicine, February 2017, Bentham Science Publishers

    vivek asati

  39. K-Ras and its inhibitors towards personalized cancer treatment: Pharmacological and structural perspectives

    Article • European Journal of Medicinal Chemistry, January 2017, Elsevier

    vivek asati

  40. Triggering PIK3CA Mutations in PI3K/Akt/mTOR Axis: Exploration of Newer Inhibitors and Rational Preventive Strategies

    Article • Current Pharmaceutical Design, December 2016, Bentham Science Publishers

    vivek asati

  41. Mutant B-Raf Kinase Inhibitors as Anticancer Agents

    Article • Anti-Cancer Agents in Medicinal Chemistry, November 2016, Bentham Science Publishers

    vivek asati

  42. QSAR studies for some thiazolidine-2,4-dione derivatives as PIM-2 kinase inhibitors

    Article • Medicinal Chemistry Research, April 2016, Springer Science + Business Media

    vivek asati

  43. PI3K/Akt/mTOR and Ras/Raf/MEK/ERK signaling pathways inhibitors as anticancer agents: Structural and pharmacological perspectives

    Article • European Journal of Medicinal Chemistry, February 2016, Elsevier

    vivek asati

  44. Molecular modeling studies of some thiazolidine-2,4-dione derivatives as 15-PGDH inhibitors

    Article • Medicinal Chemistry Research, August 2015, Springer Science + Business Media

    vivek asati

  45. Chalcone scaffolds as anti-infective agents: Structural and molecular target perspectives

    Article • European Journal of Medicinal Chemistry, August 2015, Elsevier

    vivek asati

  46. Synthesis, characterization and antimicrobial evaluation of some 1,3-benzothiazole-2-yl-hydrazone derivatives

    Article • Arabian Journal of Chemistry, July 2015, Elsevier

    vivek asati

  47. 1,3,4-Oxadiazoles: An emerging scaffold to target growth factors, enzymes and kinases as anticancer agents

    Article • European Journal of Medicinal Chemistry, June 2015, Elsevier

    vivek asati

  48. Anti-cancer chalcones: Structural and molecular target perspectives

    Article • European Journal of Medicinal Chemistry, June 2015, Elsevier

    vivek asati

  49. Chalcones and their therapeutic targets for the management of diabetes: Structural and pharmacological perspectives

    Article • European Journal of Medicinal Chemistry, March 2015, Elsevier

    vivek asati

  50. Thiazolidine-2,4-diones as multi-targeted scaffold in medicinal chemistry: Potential anticancer agents

    Article • European Journal of Medicinal Chemistry, November 2014, Elsevier

    vivek asati

  51. Raf kinase as a target for anticancer therapeutics

    Article • Molecular Cancer Therapeutics, April 2005, American Association for Cancer Research (AACR)

    vivek asati